Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reintgen

Showing results (261-270 of 310) with videos related to

Pageof 31
Sort By:
Cancer Control : Journal of the Moffitt Cancer Center|March 31, 2000
Clinical approach to neuroendocrine carcinoma of the skin (Merkel cell carcinoma)D F Smith, J L Messina, R Perrott, et al.
The Breast Journal|May 12, 2001
Lymphatic Mapping and Sentinel Lymph Node BiopsySiddharth S. Bass, Gary H. Lyman, Christa R. McCann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 9, 2007
Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011Anthony Lucci, Linda Mackie McCall, Peter D Beitsch, et al.
Annals of Surgical Oncology|January 5, 2002
Improved staging of node-negative patients with intermediate to thick melanomas (>1 mm) with the use of lymphatic mapping and sentinel lymph node biopsyS Dessureault, S J Soong, M I Ross, et al.
Annals of Surgical Oncology|July 4, 2003
Complications associated with sentinel lymph node biopsy for melanomaWilliam R Wrightson, Sandra L Wong, Michael J Edwards, et al.
The American Surgeon|January 1, 1996
The tumor biology of melanoma nodal metastasesG Miliotes, J Albertini, C Berman, et al.
Annals of Surgical Oncology|November 1, 1996
Evaluation of new putative tumor markers for melanomaG Miliotes, G H Lyman, C W Cruse, et al.
Cancer|March 1, 1996
Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapyR Heller, M J Jaroszeski, L F Glass, et al.
Annals of Surgical Oncology|April 21, 2001
Sentinel lymph node biopsy for melanoma: how many radioactive nodes should be removed?K M McMasters, D S Reintgen, M I Ross, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patientsJ E Gershenwald, W Thompson, P F Mansfield, et al.
Pageof 31

Showing results (261-270 of 310) with videos related to

Sort By:
Pageof 31
Cancer Control : Journal of the Moffitt Cancer Center|March 31, 2000
Clinical approach to neuroendocrine carcinoma of the skin (Merkel cell carcinoma)D F Smith, J L Messina, R Perrott, et al.
The Breast Journal|May 12, 2001
Lymphatic Mapping and Sentinel Lymph Node BiopsySiddharth S. Bass, Gary H. Lyman, Christa R. McCann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 9, 2007
Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011Anthony Lucci, Linda Mackie McCall, Peter D Beitsch, et al.
Annals of Surgical Oncology|January 5, 2002
Improved staging of node-negative patients with intermediate to thick melanomas (>1 mm) with the use of lymphatic mapping and sentinel lymph node biopsyS Dessureault, S J Soong, M I Ross, et al.
Annals of Surgical Oncology|July 4, 2003
Complications associated with sentinel lymph node biopsy for melanomaWilliam R Wrightson, Sandra L Wong, Michael J Edwards, et al.
The American Surgeon|January 1, 1996
The tumor biology of melanoma nodal metastasesG Miliotes, J Albertini, C Berman, et al.
Annals of Surgical Oncology|November 1, 1996
Evaluation of new putative tumor markers for melanomaG Miliotes, G H Lyman, C W Cruse, et al.
Cancer|March 1, 1996
Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapyR Heller, M J Jaroszeski, L F Glass, et al.
Annals of Surgical Oncology|April 21, 2001
Sentinel lymph node biopsy for melanoma: how many radioactive nodes should be removed?K M McMasters, D S Reintgen, M I Ross, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patientsJ E Gershenwald, W Thompson, P F Mansfield, et al.
Pageof 31